BB Biotech

BB Biotech AG is a Swiss publicly traded investment company and one of the world's largest investors in the biotechnology sector. It invests in fast-growing biotechnology companies that are developing and marketing innovative drugs. The portfolio typically consists of 20 to 35 companies, with a focus on those whose products address significant unmet medical needs. While primarily investing in publicly listed companies (at least 90% of assets), it can allocate up to 10% to private equity holdings. The firm's investment manager is Bellevue Asset Management AG.